MX2015013736A - Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de deficiencia de hierro y anemia por deficiencia de hierro. - Google Patents

Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de deficiencia de hierro y anemia por deficiencia de hierro.

Info

Publication number
MX2015013736A
MX2015013736A MX2015013736A MX2015013736A MX2015013736A MX 2015013736 A MX2015013736 A MX 2015013736A MX 2015013736 A MX2015013736 A MX 2015013736A MX 2015013736 A MX2015013736 A MX 2015013736A MX 2015013736 A MX2015013736 A MX 2015013736A
Authority
MX
Mexico
Prior art keywords
iron deficiency
prophylaxis
complexes
iii
treatment
Prior art date
Application number
MX2015013736A
Other languages
English (en)
Inventor
Wilm Buhr
Franz Dürrenberger
Felix Funk
Thomas Bark
Michael Burgert
Camillo Canclini
Diana Sieber
Susanna Burckhardt
Peter Otto Geisser
Aris Kalogerakis
Simona Mayer
Erik Philipp
Stefan Reim
Jörg Schmitt
Katrin Schwarz
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of MX2015013736A publication Critical patent/MX2015013736A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a complejos de hierro (III) y a composiciones farmacéuticas que los contienen para su uso como medicamento, en particular para el tratamiento y/o la profilaxis de los síntomas de deficiencia de hierro y anemias por deficiencia de hierro.
MX2015013736A 2013-03-28 2014-03-27 Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de deficiencia de hierro y anemia por deficiencia de hierro. MX2015013736A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13161698 2013-03-28
PCT/EP2014/056146 WO2014154797A1 (de) 2013-03-28 2014-03-27 Fe(iii)-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien

Publications (1)

Publication Number Publication Date
MX2015013736A true MX2015013736A (es) 2016-02-29

Family

ID=47997249

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015013736A MX2015013736A (es) 2013-03-28 2014-03-27 Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de deficiencia de hierro y anemia por deficiencia de hierro.

Country Status (12)

Country Link
US (1) US9248134B1 (es)
EP (1) EP2978427B1 (es)
JP (1) JP2016520538A (es)
KR (1) KR20150134353A (es)
CN (1) CN105228621A (es)
AU (1) AU2014242974A1 (es)
BR (1) BR112015024571A2 (es)
CA (1) CA2896983A1 (es)
ES (1) ES2690852T3 (es)
MX (1) MX2015013736A (es)
RU (1) RU2015146368A (es)
WO (1) WO2014154797A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3436441B1 (en) * 2016-03-31 2020-11-11 Shield TX (UK) Limited Methods for producing ferric maltol compositions from elemental iron

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101155593A (zh) * 2005-02-09 2008-04-02 维福（国际）股份公司 铁（ⅲ）络合物化合物的应用
US9394324B2 (en) * 2010-03-23 2016-07-19 Vifor (International) Ag Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
WO2012163938A1 (de) * 2011-05-31 2012-12-06 Vifor (International) Ag Fe(iii)-2,4-dioxo-1-carbonyl-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien

Also Published As

Publication number Publication date
ES2690852T3 (es) 2018-11-22
RU2015146368A (ru) 2017-05-04
WO2014154797A1 (de) 2014-10-02
BR112015024571A2 (pt) 2017-07-18
US20160015716A1 (en) 2016-01-21
EP2978427B1 (de) 2018-08-08
AU2014242974A1 (en) 2015-07-09
JP2016520538A (ja) 2016-07-14
EP2978427A1 (de) 2016-02-03
CN105228621A (zh) 2016-01-06
CA2896983A1 (en) 2014-10-02
US9248134B1 (en) 2016-02-02
KR20150134353A (ko) 2015-12-01

Similar Documents

Publication Publication Date Title
PH12016500871A1 (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
MX2020009223A (es) Anticuerpos anti-fgfr2iiib afucosilados.
PH12015501648A1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
IN2015DN01156A (es)
MX2015011897A (es) Profarmacos de fumaratos y su uso en el tratamiento de diferentes enfermedades.
MX364486B (es) Derivados de piridazinona-amidas.
TN2012000457A1 (en) Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
PH12015500724A1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
PH12016501095A1 (en) Gabapentinoids and sigma receptor ligands combinations
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
IN2014DN07326A (es)
IN2014MN01733A (es)
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
TN2013000379A1 (en) Fe(iii) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias
MX2015013736A (es) Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de deficiencia de hierro y anemia por deficiencia de hierro.
MX2015007974A (es) Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de la deficiencia de hierro y las anemias por deficiencia de hierro.
IN2014DN08294A (es)
NZ711523A (en) Use of sedoheptulose for prevention or treatment of inflammation